PharmEasy-Owned Thyrocare’s Q1 Profit Rises 60% To INR 38.3 Cr

Thyrocare’s consolidated net profit rose 59.9% to INR 38.3 Cr in Q1 FY26 from INR 23.9 Cr in the year-ago quarter

Its operating revenue grew 23% to INR 193.03 Cr during the quarter under review from INR 156.91 Cr in Q1 FY25

Including other income of INR 4.65 Cr, the company’s total income jumped 23% to INR 197.68 Cr from INR 160.53 Cr in the same quarter last year

PharmEasy-owned diagnostics laboratories chain Thyrocare’s consolidated net profit rose 59.9% to INR…